Kim Y - Search Results

1

Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer.

Lim S, Kim Y, Lee SB, Kang HG, Kim DH, Park JW, Chung D, Kong H, Yoo KH, Kim Y, Han W, Chun KH, Park JH. Lim S, et al. Among authors: kim dh, kim y. Oncogenesis. 2020 Oct 11;9(10):91. doi: 10.1038/s41389-020-00275-x. Oncogenesis. 2020. PMID: 33041328 Free PMC article.

2

Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.

Park SJ, Kong HK, Kim YS, Lee YS, Park JH. Park SJ, et al. Am J Cancer Res. 2015 Jun 15;5(7):2127-38. eCollection 2015. Am J Cancer Res. 2015. PMID: 26328244 Free PMC article.

3

miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.

Kim YS, Park SJ, Lee YS, Kong HK, Park JH. Kim YS, et al. Oncotarget. 2016 Jul 5;7(27):42261-42273. doi: 10.18632/oncotarget.9950. Oncotarget. 2016. PMID: 27304060 Free PMC article.

4

Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma.

Kong HK, Park SJ, Kim YS, Kim KM, Lee HW, Kang HG, Woo YM, Park EY, Ko JY, Suzuki H, Chun KH, Song E, Jang KY, Park JH. Kong HK, et al. Oncotarget. 2016 Aug 23;7(34):55677-55689. doi: 10.18632/oncotarget.10972. Oncotarget. 2016. PMID: 27494879 Free PMC article.

5

Transgenic overexpression of human LY6K in mice suppresses mature T cell development in the thymus.

Son D, Kong HK, Kim Y, Song MJ, Kim HP, Lee HW, Park JH. Son D, et al. Among authors: kim hp, kim y. Oncol Lett. 2019 Jan;17(1):379-387. doi: 10.3892/ol.2018.9548. Epub 2018 Oct 4. Oncol Lett. 2019. PMID: 30655778 Free PMC article.

6

miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.

Son D, Kim Y, Lim S, Kang HG, Kim DH, Park JW, Cheong W, Kong HK, Han W, Park WY, Chun KH, Park JH. Son D, et al. Among authors: kim dh, kim y. Cancer Lett. 2019 Jul 10;454:224-233. doi: 10.1016/j.canlet.2019.04.006. Epub 2019 Apr 17. Cancer Lett. 2019. PMID: 31004703

7

Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness.

Oh C, Kim HR, Oh S, Ko JY, Kim Y, Kang K, Yang Y, Kim J, Park JH, Roe JS, Yoo KH. Oh C, et al. Among authors: kim hr, kim j, kim y. Cancers (Basel). 2021 Jun 25;13(13):3176. doi: 10.3390/cancers13133176. Cancers (Basel). 2021. PMID: 34202157 Free PMC article.

8

Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and/or ATG2B.

Park JW, Kim Y, Lee SB, Oh CW, Lee EJ, Ko JY, Park JH. Park JW, et al. Among authors: kim y. Mol Oncol. 2022 May;16(9):1857-1875. doi: 10.1002/1878-0261.13180. Epub 2022 Jan 26. Mol Oncol. 2022. PMID: 35029026 Free PMC article.

9

Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer.

Kim Y, Ko JY, Lee SB, Oh S, Park JW, Kang HG, Kim DH, Chung D, Lim S, Kong H, Kim J, Yoo KH, Han W, Chun KH, Park JH. Kim Y, et al. Among authors: kim dh, kim j. Oncogene. 2022 May;41(22):3151-3161. doi: 10.1038/s41388-022-02326-6. Epub 2022 Apr 30. Oncogene. 2022. PMID: 35490208 Free PMC article.

10

Hypomethylation of ATP1A1 Is Associated with Poor Prognosis and Cancer Progression in Triple-Negative Breast Cancer.

Kim Y, Ko JY, Kong HK, Lee M, Chung W, Lim S, Son D, Oh S, Park JW, Kim DY, Lee M, Han W, Park WY, Yoo KH, Park JH. Kim Y, et al. Among authors: kim dy. Cancers (Basel). 2024 Apr 25;16(9):1666. doi: 10.3390/cancers16091666. Cancers (Basel). 2024. PMID: 38730618 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,095 results

Search Page

Filters